| Titre : | Factors associated with 12 months continuous heroin abstinence: findings from the australian treatment outcome study (ATOS) |
| Titre traduit : | (Facteurs associés à l'abstinence ininterrompue d'héroïne durant 12 mois. Données issues de l'ATOS, Australian Treatment Outcome Study, Etude Australienne des Résultats de Traitement) |
| Auteurs : | S. DARKE ; J. ROSS ; M. TEESSON ; R. ALI ; R. COOKE ; A. RITTER ; M. LYNSKEY |
| Type de document : | Périodique |
| Année de publication : | 2005 |
| Format : | 255-263 / graph. ; tabl. |
| Note générale : |
Journal of Substance Abuse Treatment, 2005, 28, (3), 255-263 |
| Langues: | Anglais |
| Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
| Mots-clés : |
Thésaurus mots-clés EVALUATION ; ETUDE LONGITUDINALE ; DEPENDANCE ; HEROINE ; ABSTINENCE ; DUREE ; TRAITEMENT ; TRAITEMENT RESIDENTIEL ; INJECTION ; DEVENIRThésaurus géographique AUSTRALIE |
| Résumé : |
ENGLISH : Aims: To determine the role of treatment and client characteristics associated with the achievement of continuous heroin abstinence. Design: Longitudinal cohort study. Setting: Sydney and Adelaide, Australia. Participants: 570 heroin users re-interviewed at 12 month follow-up for the Australian Treatment Outcome Study (ATOS). Findings: Continuous heroin abstinence was reported by 14% of participants. Continuous abstinence was associated with no previous treatment history, having entered treatment at baseline, and cumulative treatment exposure over the follow-up period. Longer retention times in index maintenance and residential rehabilitation treatments, but not detoxifications, were most associated with abstinence. At baseline, abstinent participants were more Likely to have been classified as treatment ready, or to have used heroin less frequently; and less likely to have been daily injectors, using cocaine or criminally involved. Conclusions: Approximately 14% of ATOS participants achieved continuous heroin abstinence over 12 months. Such an achievement was strongly associated with a longer "dose" of treatment, and with more treatment stability over the follow-up period. (Editor's abstract.) |
| Note de contenu : | graph. ; tabl. |
| Domaine : | Drogues illicites / Illicit drugs |
| Refs biblio. : | 37 |
| Affiliation : |
National Drug and Alcohol Research Centre, University of New South Wales, NSW, 2052. E-mail : s.darkeunsw.edu.au Australie. Australia. |
| Numéro Toxibase : | 405071 |
| Centre Emetteur : | 04 CIRDD-51 |
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Accueil
